Adela
PrivateLast Round
Seed Round
Apr 10, 2026
Total Funding Raised
$108M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adela operates in Healthcare & Life Sciences and is based in Foster City, California. Its latest recorded funding round was a Series A Extension round in September 2023.
Adela is a healthcare technology company that develops blood-based diagnostic tests for minimal residual disease monitoring and multi-cancer early detection using a genome-wide methylome enrichment platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adela Comparables
Compare Adela with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exai Bio | 86% | |
| Lucence | 85% | |
| Delfi Diagnostics | 84% |
For institutional investors. Book with your work email.
Adela Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 10, 2026 | ||||
| Seed Round | Oct 10, 2023 | ||||
| Series A Extension | Sep 25, 2023 | ||||
| Seed Round | Jul 14, 2021 | ||||
| Series A | Jun 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Adela Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A Extension, Series A |
| RA Capital Management | Series A Extension, Series A |
| F-Prime Capital | Series A Extension, Series A |
| OrbiMed | Series A Extension, Series A |
| F-Prime Capital | Series A Extension, Series A |
| Decheng Capital | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 40% MoM.
- Apr 10, 2026
$5M round raised.
For institutional investors. Book with your work email.
Adela Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adela's valuation, stock price, and market status.
Is Adela a public or private company?
Adela is a private company.
What is the current stock price of Adela?
Adela is a private company, so its shares have no public market price. Caplight tracks Adela's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adela worth (valuation)?
Valuation information for Adela is not publicly available.
Can I buy Adela stock?
Adela shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adela's last funding round?
Adela's most recent funding round was Seed Round on April 10, 2026.
Who are the main investors in Adela?
Key investors in Adela include F-Prime Capital, F-Prime Capital.
Will Adela IPO soon?
No public IPO plans have been announced for Adela.
How can I track Adela secondary market activity?
Caplight tracks bids, offers, and trades in Adela's shares on secondary markets.